Asahi Kasei Medical Co. Ltd. recently announced that it will acquire California-based Bionova Scientific LLC, a CDMO for biopharmaceuticals. The…...
Please subscribe to read the full story.
biopharmaceuticals
AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More
AGC Inc. (TYO:5201) is looking to invest more than 200 billion yen ($1.7 billion) into CDMO operations by 2025. Plans…...
Please subscribe to read the full story.
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO Mass Production in Japan
Biotech venture Chitose Bio Evolution Pte. Ltd. is setting out to build a contract development and manufacturing organization (CDMO) production…...
Please subscribe to read the full story.
